1. State biosimilar substitution laws could reduce consumer access and savings Author(s): Purvis, Leigh, authorMcSpadden, James, author Publication: Washington, DC : AARP Public Policy Institute, October 2022 Subject(s): Biosimilar PharmaceuticalsCost SavingsHealth Services AccessibilityLegislation, DrugDrug CostsState GovernmentUnited States
